Duke Health: Drug for CMV Infections Among Pregnant Woman Proves Ineffective
July 29, 2021
July 29, 2021
DURHAM, North Carolina, July 29 (TNSRes) -- Duke Health issued the following news release:
A commonly used treatment for pregnant women infected with a virus that can cause deafness and other harms to newborns provides no benefit, according to a large, multi-center study led by a researcher at Duke Health.
The study was designed to determine whether monthly infusions of hyperimmune globulin were effective in preventing the transmission of cytomegalovirus (CMV) infection . . .
A commonly used treatment for pregnant women infected with a virus that can cause deafness and other harms to newborns provides no benefit, according to a large, multi-center study led by a researcher at Duke Health.
The study was designed to determine whether monthly infusions of hyperimmune globulin were effective in preventing the transmission of cytomegalovirus (CMV) infection . . .